Gala vs Henry Meds: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Henry Meds beats Gala overall, scoring 8.4/10 vs 7/10. Gala is more affordable at $149/mo vs $199/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Henry Meds for users seeking a well-rounded program with good pricing and m.
A side-by-side comparison of Gala and Henry Meds covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaHenry Meds
#6 of 42Popular telehealth platform offering a wide range of GLP-1 options with competitive pricing and reliable service.
Visit Henry Meds| Feature | Gala | Henry Meds |
|---|---|---|
| Our Score | 7/10 | 8.4/10 |
| Starting Price | $149/mo | $199/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users seeking a well-rounded program with good pricing and medication variety |
| Ranking | #40 | #6 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Henry Meds
Pros
- +Strong medication variety — both brand-name (Wegovy, Zepbound) and compounded options under one roof
- +$199/mo is well-priced for a platform offering both medication types with clinical support
- +Active patient community and responsive support team with typical <4 hour email response times
- +Easy medication switches — can move from compounded to brand-name (or vice versa) without re-enrollment
Cons
- −No insurance billing — $199/mo is entirely out-of-pocket, though they provide superbills
- −Consultation wait times can stretch to 3-5 days during peak periods (January, post-holiday)
Our Verdict
Henry Meds edges out Gala with a score of 8.4/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Henry Meds's $199/mo. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Henry Meds if you want: users seeking a well-rounded program with good pricing and medication variety.